Monday, November 14, 2016

UPDATE 3-U.S. FDA rejects Dynavax's hepatitis B vaccine; shares sink

Nov 14 (Reuters) - The U.S. Food and Drug Administration

rejected Dynavax Technologies Corp's hepatitis B

vaccine for the second time in three years, casting doubts on

the drug developer's ability to...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)